A new weapon in the fight against osteoarthritis?
Researchers at ETH Zurich, Empa and the Norwegian research institute SINTEF are pursuing a new approach to treating osteoarthritis. This is based on a polysaccharide, a long-chain sugar molecule, originating from brown algae. When chemically modified, this “alginate” reduces oxidative stress, has an anti-inflammatory effect in cell culture tests and suppresses the immune reaction against cartilage cells, thereby combating the causes of arthritis. The research is, however, still in its infancy.
Osteoarthritis is the most-widespread joint disease, with around 90 percent of all people over 65 being affected to varying degrees, but this degenerative disease is also widespread amongst younger people. In arthritis, the cartilage in the joint, a type of protective layer on bones that “lubricates” the joint, degenerates over time. This can be extremely painful for sufferers, because inflammatory reactions are associated with cartilage degeneration. In the later stages of the disease, bones are no longer adequately protected and can directly rub against each other.
Osteoarthritis can affect all joints in the body, but most often affects the knee joint, hip joint and fingers. The disease has been considered incurable until now. Current treatment methods, such as anti-inflammatory drugs and painkillers, mainly address the symptoms. Often, the only remaining option is an operation to replace the affected joint with an artificial one.
Initial research results are encouraging
In laboratory tests, the team led by ETH researcher Marcy Zenobi-Wong and Empa researcher Katharina Maniura has now succeeded, together with SINTEF in Norway, in identifying a substance with the potential to halt cartilage degeneration in joints. This substance is the polysaccharide alginate extracted from the stems of brown algae – or more precisely cuvie (Lat. Laminaria hyperborea), which is similar to specific extracellular biomolecules in cartilage. The researchers chemically modified the alginate with sulfate groups and then added it in dissolved form to cell cultures to examine the reaction of various cell types to the modified polysaccharide. This revealed that alginate sulfate can significantly reduce oxidative stress, which is a frequent cause of cell damage or even cell death, and the more sulfate groups attached to the alginate molecule, the greater this reduction.
Alginate sulfate was also able to suppress the inflammatory reaction, again depending on the number of sulfate groups, and was able to down-regulate the expression of genes that trigger an inflammatory reaction in both human cartilage cells, known as chondrocytes, and in macrophages, the “scavenger cells” of our immune system. The algal molecules should therefore slow down cartilage degeneration. “The hope is that they can even stop this degeneration,” says Empa researcher Markus Rottmar.
Further research work necessary
The alginate sulfates have so far only been tested in vitro, i.e. in the laboratory with cell cultures. However, the encouraging results mean that research will now continue. The next stage is to test the substances on animals. If this is also successful, clinical trials can then be conducted on people. These tests are, however, laborious and time-consuming. If everything were to work perfectly, it would still be a few years before arthritis patients could be treated with alginate sulfate.
Learn more: Treating arthritis with algae
The Latest on: Osteoarthritis
[google_news title=”” keyword=”osteoarthritis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- If detected early, osteoarthritis can be 'arrested' to restore joint healthon April 27, 2024 at 3:55 am
A team of researchers in the US predicted knee osteoarthritis via a blood test at least eight years before tell-tale signs of the disease appeared on.health. healthcare. fitness. wellness. well-being.
- Breakthrough blood test predicts osteoarthritis 8 years earlyon April 27, 2024 at 2:51 am
Blood test identifies knee osteoarthritis up to 8 years before X-ray detection. NEW YORK, April 27: Scientists have identified a potential breakthrough in the early detection of knee osteoarthritis, s ...
- Blood test predicts knee osteoarthritis eight years before tell-tale signs of the diseaseon April 26, 2024 at 10:53 pm
A blood test successfully predicted knee osteoarthritis at least eight years before tell-tale signs of the disease appeared on x-rays, Duke Health researchers report.
- Blood test may be able to detect osteoarthritis 8 years earlier than X-rayon April 26, 2024 at 12:00 pm
A blood test could help predict knee osteoarthritis at least eight years before the signs of the disease show up on X-rays, a new study indicates.
- Blood test powered by AI could catch osteoarthritis 8 years earlier than X-ray, early data showon April 26, 2024 at 11:00 am
A new blood test could determine whether someone will develop knee osteoarthritis up to eight years before structural damage is picked up by an X-ray.
- Blood test finds knee osteoarthritis up to 8 years before it appears on X-rayson April 26, 2024 at 11:00 am
Detecting knee osteoarthritis with a blood test up to eight years before it appears on X-rays -- as researchers have done -- could lead to therapies that delay disease progression and restore joint ...
- Blood Test Detects Knee Osteoarthritis 8 Years Before X-Rayson April 26, 2024 at 11:00 am
Early detection of knee osteoarthritis could lead to therapies that slow progression and restore joint health. A blood test successfully predicted knee osteoarthritis at least eight years before ...
- Rheumatoid Arthritis and Osteoarthritis patients genetically susceptible for developing COPD, suggests studyon April 26, 2024 at 8:00 am
Rheumatoid Arthritis and Osteoarthritis patients are genetically susceptible to developing COPD, suggests a study published in the Frontiers in Medicine.Observational studies have reported ...
- Self-administered acupressure reduces knee pain with suspected osteoarthritison April 24, 2024 at 12:31 pm
Self-administered acupressure (SAA) is an efficacious and cost-effective approach to relieve knee pain in middle-aged and older adults with probable knee osteoarthritis (OA), according to a study ...
- Semaglutide Improves Knee Osteoarthritis Pain, Physical Function in Phase 3 Trialon April 23, 2024 at 4:08 am
Results of the STEP 9 study in people with knee OA and obesity show that semaglutide not only induced significant weight loss but also improved knee pain and physical function.
via Google News and Bing News